Ceapro

Ceapro EV/EBIT

Delisted

The EV/EBIT (Enterprise Value to EBIT) of Ceapro (CZO.V) as of Oct 31, 2026 is -2.82. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 3.32 — a change of -184.95% (lower).

EV/EBIT

-2.82

YoY

-184.95%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Ceapro is 2023 -2.82 . EV/EBIT (Enterprise Value to EBIT) of Ceapro was 2022 3.32 . It decreases by -184.95% lower compared to the previous year.

The Ceapro EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2016
2.94 CAD
Jan 1, 2017
6.63 CAD
Jan 1, 2018
137.57 CAD
Jan 1, 2019
-24.00 CAD
Jan 1, 2020
8.33 CAD
Jan 1, 2021
7.29 CAD
Jan 1, 2022
3.32 CAD
Jan 1, 2023
-2.82 CAD
The Ceapro EV/EBIT history
YEAREV/EBITYoY
-2.82-184.95%
3.32-54.53%
7.29-12.46%
8.33-134.71%
-24.00-117.44%
137.57+1,974.14%
6.63+125.83%
2.94-39.49%
4.85-44.91%
8.81—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ceapro Stock analysis

What does Ceapro do? Ceapro Inc is an innovative biotechnology company based in Edmonton, Canada. The company was founded in 1997 and has since specialized in the development of natural, biological ingredients from plants. It is listed on the Toronto Stock Exchange and has become a key player in the field of natural-based medicine and cosmetics in recent years. Ceapro's business model is based on the research and production of active compounds from plant-based raw materials. The company employs gentle extraction methods that preserve the effectiveness of the ingredients and enable environmentally friendly production. Ceapro collaborates closely with research and industry to ensure the best possible effectiveness and applicability of its products. The company's products are divided into various segments tailored to the needs of customers. One important segment is medicine, where Ceapro focuses on the development of herbal remedies. The company has already developed some promising products in this area, which can be used, for example, for inflammation, pain, or diabetes. Another important segment of Ceapro is cosmetics, where the company researches and produces natural ingredients for skin and hair care. These products are known for their high effectiveness, tolerability, and environmental friendliness. One of the company's most famous products is Avenanthramide, an ingredient derived from oats that offers anti-aging and anti-inflammatory properties. Ceapro also places special emphasis on the development of digestive-aid ingredients that can be used in the food industry. The company relies on plant enzymes and compounds that help support and relieve the digestive system. The use of natural ingredients ensures high tolerability and usability. Over the course of its history, Ceapro Inc has already won numerous awards and prizes that confirm the high quality of its products and the company's innovative power. For example, the company has been repeatedly honored with the Alberta Venture Fast Growth 50 Award and also received the Environmental Stewardship Award from the Edmonton Chamber of Commerce. Ceapro is not only an innovative biotechnology company specializing in the research and production of plant-based ingredients but also an important player in the fields of medicine and cosmetics. The company employs gentle extraction methods and collaborates closely with research and industry to achieve the best possible effectiveness and applicability. The different products are divided into the segments of medicine, cosmetics, and food and are known for their high effectiveness, tolerability, and environmental friendliness. Ceapro is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ceapro stock

EV/EBIT (Enterprise Value to EBIT) of Ceapro is -2.82 in 2023.

EV/EBIT (Enterprise Value to EBIT) of Ceapro changed from 3.32 to -2.82, representing a -184.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Ceapro since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Ceapro with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ceapro

All Key Metrics — Ceapro